CMAJ OPEN, 2(3) E127
Research
CMAJ OPENA ccording to world-wide estimates, human papillomavirus (HPV) infection is responsible for 5.2% of all cancers. 1,2 The association between HPV and cervical cancer has been well-known for many decades, but the link between HPV and cancers of the anus, penis, vagina, vulva and oropharynx has only recently been confirmed.3 Cervical cancer rates have been declining in Canada and the United States, consistent with the successful adoption of Papanicolaou smear screening programs, 4,5 but the incidence of other HPV-related cancers has been increasing. The increasing incidence of these HPV-related cancers has been attributed to changes in lifestyle-related risk factors, most notably sexual behaviour.5 Analysis of trends in incidence and birth cohorts in both the US and the United Kingdom have shown an increased risk of HPV-related cancer in more recent birth cohorts and recent time periods, 5,6 and these increases have been attributed to generational changes in sexual patterns and increased exposure to HPV. 6 HPV vaccines are now broadly used in the prevention of cervical cancer. In Alberta, HPV vaccination programs were implemented in 2008 and, as in many other jurisdictions, have been funded only for females. Although HPV vaccination programs may reduce the incidence of HPV-related cancers other than cervical cancer, 6 they remain the subject of much public policy debate in Canada. 7 In this study, we sought to examine trends in noncervical HPV-related cancers over time and compare them with relative changes in cervical cancer and non-HPV-related cancers with similar risk factors.